Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing
Podcast Image

NPR News Now

NPR News: 04-01-2026 2PM EDT

01 Apr 2026

Transcription

Transcript generated automatically by AI and may contain errors.

Chapter 1: What is the main topic discussed in this episode?

1.212 - 5.46 Lakshmi Singh

Live from NPR News, I'm Lakshmi Singh. The U.S.

0

Chapter 2: What are the Supreme Court's arguments regarding birthright citizenship?

5.48 - 25.836 Lakshmi Singh

Supreme Court will now weigh arguments over the future of birthright citizenship. Today, a majority of justices, including some who President Trump nominated, seem skeptical about the administration's effort to limit the constitutional provision. But NPR's Kerry Johnson reports the outcome remains far from certain.

0

25.816 - 41.03 Kerry Johnson

President Trump issued an executive order on day one that would end citizenship to babies born to people who are in the country illegally or here to work or visit on a temporary basis. If the Supreme Court agrees, that order could affect 250,000 babies born in the U.S.

0

Chapter 3: How is President Trump addressing the ongoing Iran war?

41.091 - 62.337 Kerry Johnson

each year and potentially be used to help revoke the citizenship of many others born earlier. Trump attended for the Solicitor General's arguments but left as Attorney Cecilia Wong made her case. for people challenging his order. Wong told the justices to agree with the president would radically rewrite the Constitution and upend more than 150 years of settled law.

0

62.777 - 66.142 Kerry Johnson

A decision is expected near the end of the Supreme Court term this summer.

0

Chapter 4: What new obesity pill has the FDA approved and how does it differ from previous medications?

66.523 - 68.065 Kerry Johnson

Carrie Johnson, NPR News.

0

69.347 - 82.543 Lakshmi Singh

President Trump is expected to address the nation about the Iran war tonight at 9 Eastern. The conflict the U.S. and Israel began against the Islamic Republic is in its fifth week. Thousands of U.S. troops are stationed in the region.

0

Chapter 5: What historic mission are Artemis II astronauts preparing for?

83.224 - 90.602 Lakshmi Singh

Trump now says the Iranian regime is relenting, but that appears to be very much in dispute. NPR's Deepa Shivaram has more.

0

90.616 - 100.51 Deepa Shivaram

On social media, Trump said Iran's new leader asked the U.S. for a ceasefire. The president said he would consider it if the Strait of Hormuz, a critical route for oil, was opened.

0

Chapter 6: How is NASA addressing diversity in its upcoming lunar mission?

100.85 - 118.935 Deepa Shivaram

Until then, Trump said the U.S. would continue its attacks on Iran. But Iran's foreign ministry called Trump's comments saying that Iran asked for a ceasefire, quote, false and baseless. Trump has said the war, which has gone on for a month, should end in the next two to three weeks. Deepa Shivaram, NPR News, the White House.

0

119.354 - 130.068 Lakshmi Singh

The Food and Drug Administration approved another obesity pill today, this one from drug maker Eli Lilly. NPR's Sydney Lepkin reports on how this medicine is different.

0

130.468 - 148.011 Sydney Lepkin

Eli Lilly's new pill is called Fundeo. Although this is the same company behind Zepbound, the blockbuster injectable obesity medicine, Eli Lilly decided not to take Zepbound's main ingredient and make it in pill form. Instead, the company developed a new ingredient, Orfaglipron.

0

148.328 - 159.26 Sydney Lepkin

Daniel Skowronski, the company's chief scientific and medical officer, says until now, all of these GLP-1 drugs have been peptides, meaning they need to be taken as injections or as a pill with restrictions.

0

159.561 - 161.463 Unknown

Make something as simple as possible.

Chapter 7: What changes is Hershey making to its Reese's products?

161.743 - 164.406 Unknown

That means we had to rely on more complicated science.

0

164.426 - 178.96 Sydney Lepkin

Lilly hasn't announced a list price yet, but it says people with commercial insurance could pay as little as $25 a month, and for people paying cash, the lowest dose will cost $149 a month. Sydney Lepkin, NPR News. You're listening to NPR.

0

182.028 - 204.547 Lakshmi Singh

Artemis II astronauts are heading to the launch pad for a historic trip around the moon and back. NASA is preparing to launch four people from Florida's Kennedy Space Center for the first lunar mission in 54 years. Never before has a black man or a woman flown on such a mission, but NPR's Katie Riddle reports that lately NASA has not been talking much about these firsts.

0

204.748 - 224.151 Unknown

When the crew was first announced a few years ago, NASA officials were proud to highlight these achievements. But that was before President Trump returned to office and signed executive actions targeting diversity, equity and inclusion efforts across federal agencies. Since then, NASA has removed language from their website celebrating the crew's diversity.

0

224.131 - 227.056 Unknown

AJ Link is from the group Black in Astro.

227.076 - 242.041 AJ Link

I think it's really important to explicitly highlight the inclusion of not just Black folks, but other marginalized folks that have been left out of the industry. And to back away from that or to erase that, I think is wrong.

242.382 - 248.552 Unknown

After this mission, NASA is planning for another, possibly returning to the moon's surface. Katie Riddle, NPR News.

248.988 - 266.907 Lakshmi Singh

Hershey knows not everyone's sweet on its Reese's products these days. So it's going back to basics. Brad Reese, whose grandfather invented Reese's peanut butter cups, didn't like it when Hershey took the cost-saving measure of replacing milk chocolate and peanut butter with cheaper ingredients. He made his feelings known in a public letter on Valentine's Day.

267.488 - 278.64 Lakshmi Singh

Well, today, Hershey said it will go back to classic recipes for all Reese's products starting next year. The Dow is up 324 points. It's NPR News.

Comments

There are no comments yet.

Please log in to write the first comment.